The initial success of Viagra undeniably reshaped the pharmaceutical landscape, but betting in companies primarily reliant on off-patent versions presents a challenging picture. Despite early earnings were substantial, the end of patents and the appearance of cheaper alternatives have eroded market share. Thus, a thorough analysis of current revenu